Share Prices & Company Research

Market News

26 May 2020 | 08:51

PureTech Health lowers stake in founded entity

(Sharecast News) - Clinical stage biotechnology company PureTech Health said on Tuesday that it had received $45m from the sale of 555,500 shares of its founded entity Karuna Therapeutics. Following the transaction, PureTech will continue to hold 4.73m shares in Karuna, equal to 18.1% of the group, and has a right to royalty payments on net sales of any commercialised product covered by a license granted by PureTech to Karuna.

The FTSE 250-listed group intends to use the proceeds from the transaction to fund its growth potential.

PureTech has generated over $255m in the past six months from the combined sales of minority portions of founded entity shares.

As of 0850 BST, PureTech shares were up 1.42% at 252.03p.
Get in touch today
Join Redmayne Bentley
Talk to us now about opening a new account or transferring your account from another provider
0113 243 6941
Get in touch today
Contact your local office
Contact your local office to find out more
The value of your investments and the income from them may go down as well as up, and you could get back less than you invested.
Continuing our Personal Service: View our Latest COVID-19 Update: 15th January 2021
We use cookies on this site to improve your experience and help us provide you with a better website. An explanation of the cookies we use and their purpose can be found within our Cookie Policy. Your continued use of this site means you consent to the use of cookies.